In TCGA cases, 54.41% mucinous adenocarcinoma cases were non-mutated both in TP53 (−) and BRAF (−), and 61.16% other adenocarcinoma cases were TP53 mutated (+) and BRAF (−) (Fig. 3a and c). This evidence concerns the gene BRAF and mucinous adenocarcinoma.